| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Fennec Pharmaceuticals Inc. (FENC) have been net sellers, shedding 112,545 shares worth roughly $1.3M on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $29.37M | - | |
| CFO | 248.6K | $2.66M | - | |
| Dir | 124.4K | $1.33M | - | |
| CEO | 70.8K | $758.0K | - | |
| Dir | 63.1K | $674.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $9.78 | $97,800.00 | -10.8% | -23.0% | +6.3% | |
| Sep 4, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $8.92 | $89,200.00 | -16.4% | -17.5% | +35.0% | |
| Aug 5, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $8.09 | $80,900.00 | -15.2% | -0.5% | +28.8% | |
| Jul 7, 2025 | Chris A Rallis60 | Director | Sale+OE10b5-1 | 1,119 | $8.71 | $9,746.49 | -2.0% | +15.0% | +24.0% | |
| Jul 3, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $8.61 | $86,100.00 | -14.2% | +9.0% | +21.6% | |
| Jun 5, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $7.78 | $77,800.00 | -13.3% | +12.2% | +10.1% | |
| May 19, 2025 | Jeffrey S. Hackman | Chief Executive Officer | Buy | 15,000 | $6.97 | $104,601.60 | New | +7.2% | +27.6% | |
| May 16, 2025 | Rosty Raykov51 | Director | Sell | 16,667 | $6.78 | $113,002.26 | -19.2% | +24.7% | +42.5% | |
| May 5, 2025 | Rosty Raykov51 | Director | Sell10b5-1 | 10,000 | $6.31 | $63,100.00 | -15.7% | +32.5% | +7.0% | |
| Apr 11, 2025 | Chris A Rallis60 | Director | Sale+OE10b5-1 | 1,409 | $4.95 | $6,974.55 | -2.6% | +80.4% | +16.0% |